AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Adaptimmune Therapeutics (ADAP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.57

-0.01 (-1.55%)

At close: Jan 28, 2025, 1:39 PM

Adaptimmune Therapeutics Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ADAP stock have an median target of 3.15, with a low estimate of 3 and a high estimate of 3.5. The median target predicts an increase of 452.63% from the current stock price of 0.57.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3	$3.22	$3.15	$3.5
Change	426.32%	464.91%	452.63%	514.04%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Adap... Unlock content with Pro Subscription

Updated Nov 19, 2024

Rating	May 24	Jul 24	Aug 24	Nov 24
Strong Buy	0	0	0	0
Buy	2	1	2	4
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	1	2	4

Financial Forecast this Year

Revenue This Year

182.53M

from 60.28M

202.8%

from 60.28M

Revenue Next Year

39.78M

from 182.53M

-78.2%

from 182.53M

EPS This Year

-0.03

from -0.09

66.7%

from -0.09

EPS Next Year

-0.08

from -0.03

-166.7%

from -0.03